{"log_id": 8213370312346964691, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0, "average": 0.994441, "min": 0.994441}, "location": {"width": 24, "top": 189, "height": 26, "left": 121}, "words": "遗"}, {"probability": {"variance": 4e-06, "average": 0.998674, "min": 0.994271}, "location": {"width": 147, "top": 235, "height": 29, "left": 127}, "words": "【药理毒理】"}, {"probability": {"variance": 1.9e-05, "average": 0.998601, "min": 0.975224}, "location": {"width": 819, "top": 283, "height": 30, "left": 177}, "words": "本品为阿片受体拮抗药,本身几乎无药理活性,但能竞争性拮抗各类阿"}, {"probability": {"variance": 0.002779, "average": 0.979616, "min": 0.796949}, "location": {"width": 395, "top": 333, "height": 30, "left": 121}, "words": "片受体,对μ受体有很强的亲和力"}, {"probability": {"variance": 1e-06, "average": 0.998546, "min": 0.997642}, "location": {"width": 152, "top": 384, "height": 29, "left": 207}, "words": ")药理作用"}, {"probability": {"variance": 0.014474, "average": 0.933328, "min": 0.544086}, "location": {"width": 456, "top": 413, "height": 61, "left": 170}, "words": "1完全或部分纠正阿片类物游"}, {"probability": {"variance": 6e-06, "average": 0.998756, "min": 0.992057}, "location": {"width": 355, "top": 433, "height": 28, "left": 639}, "words": "制效应,如呼吸抑制、镇静和低"}, {"probability": {"variance": 1e-06, "average": 0.998879, "min": 0.997982}, "location": {"width": 48, "top": 484, "height": 26, "left": 211}, "words": "血压"}, {"probability": {"variance": 1e-05, "average": 0.998293, "min": 0.989665}, "location": {"width": 319, "top": 528, "height": 36, "left": 209}, "words": "对动物急性乙醇中毒有促醒"}, {"probability": {"variance": 0.065262, "average": 0.759687, "min": 0.39865}, "location": {"width": 55, "top": 460, "height": 120, "left": 601}, "words": "以业"}, {"probability": {"variance": 0.013087, "average": 0.968143, "min": 0.3998}, "location": {"width": 826, "top": 576, "height": 34, "left": 169}, "words": "3.为纯阿片受体拮抗剂,即不具有其他阿受体拮抗剂的“激动性”或"}, {"probability": {"variance": 0.005774, "average": 0.980745, "min": 0.611028}, "location": {"width": 661, "top": 625, "height": 33, "left": 111}, "words": "吗啡样效应;不引起呼吸抑制、拟精神病反应或缩瞳反应"}, {"probability": {"variance": 0.000232, "average": 0.98884, "min": 0.953623}, "location": {"width": 485, "top": 678, "height": 31, "left": 172}, "words": "1.未见耐药性,也未见生理或精神依赖性"}, {"probability": {"variance": 0.013154, "average": 0.972412, "min": 0.382515}, "location": {"width": 823, "top": 728, "height": 31, "left": 170}, "words": "虽然作用机理尚不完全清楚,但是,有充分证据表明是通过竞争相同"}, {"probability": {"variance": 0.000133, "average": 0.9951, "min": 0.956345}, "location": {"width": 366, "top": 779, "height": 29, "left": 109}, "words": "受体位点拮抗阿片类物质效应的"}, {"probability": {"variance": 1.5e-05, "average": 0.99776, "min": 0.989981}, "location": {"width": 125, "top": 829, "height": 29, "left": 205}, "words": ")临床药理"}, {"probability": {"variance": 3.8e-05, "average": 0.998025, "min": 0.971591}, "location": {"width": 821, "top": 876, "height": 32, "left": 171}, "words": "在一项由中华神经外科学会和中华神经外科杂志组织的临床研究中,全"}, {"probability": {"variance": 1e-05, "average": 0.998819, "min": 0.985203}, "location": {"width": 836, "top": 926, "height": 33, "left": 156}, "words": "8家大型医院(包括神经专科医院)对纳洛酮注射液治疗急性颅脑损伤进"}, {"probability": {"variance": 5.1e-05, "average": 0.99714, "min": 0.962356}, "location": {"width": 873, "top": 977, "height": 32, "left": 117}, "words": "行了双盲随机对照临床研究。共完成500余例,试验组是在基础治疗方案上"}, {"probability": {"variance": 0.00564, "average": 0.986159, "min": 0.517886}, "location": {"width": 871, "top": 1028, "height": 31, "left": 119}, "words": "加入本品,用药剂量为0.3mg/kg体重/日,用生理盐水或平衡液稀释至500m1"}, {"probability": {"variance": 6.4e-05, "average": 0.997227, "min": 0.952573}, "location": {"width": 871, "top": 1078, "height": 32, "left": 116}, "words": "后使用输液泵24小时持续滴注,连用3日后,统一减量为4.8mg/日,连续"}, {"probability": {"variance": 0.002324, "average": 0.99039, "min": 0.717834}, "location": {"width": 863, "top": 1128, "height": 31, "left": 116}, "words": "7日后停药。结果试验组与未加入本品而仅用基础治疗的安慰剂对照组比较"}, {"probability": {"variance": 1.9e-05, "average": 0.998118, "min": 0.976936}, "location": {"width": 871, "top": 1175, "height": 36, "left": 118}, "words": "试验组死亡率为12.5%,安慰剂对照组为17.3%,两组有显著性差异,并"}, {"probability": {"variance": 0.003529, "average": 0.985721, "min": 0.64958}, "location": {"width": 872, "top": 1225, "height": 35, "left": 117}, "words": "且试验组GCS评分、GOS评分、语言运动功能和生活质量评分均明显优于安"}, {"probability": {"variance": 0.00086, "average": 0.993549, "min": 0.831093}, "location": {"width": 852, "top": 1275, "height": 38, "left": 113}, "words": "慰剂组。在治疗期间共有8名病人在用药后出现不同程度的肝肾功能异常"}, {"probability": {"variance": 0.000737, "average": 0.989195, "min": 0.905109}, "location": {"width": 320, "top": 1330, "height": 29, "left": 116}, "words": "无证据证明为与用药有关"}, {"probability": {"variance": 0.005058, "average": 0.95735, "min": 0.815789}, "location": {"width": 105, "top": 1382, "height": 27, "left": 170}, "words": "(三)毒理"}, {"probability": {"variance": 0.001049, "average": 0.989189, "min": 0.854087}, "location": {"width": 821, "top": 1428, "height": 32, "left": 167}, "words": "1.单剂量静脉给药,大鼠和小鼠的LD50分别为150mg/kg、109mg/kg;单"}, {"probability": {"variance": 0.000891, "average": 0.989831, "min": 0.853918}, "location": {"width": 539, "top": 1479, "height": 33, "left": 116}, "words": "剂量皮下注射给药,新生大鼠LD50为260mg/kg"}, {"probability": {"variance": 1.7e-05, "average": 0.998601, "min": 0.981949}, "location": {"width": 505, "top": 1529, "height": 32, "left": 166}, "words": "尚未进行过可评价的本品致癌性动物实验"}, {"probability": {"variance": 0.000618, "average": 0.992271, "min": 0.871778}, "location": {"width": 825, "top": 1578, "height": 37, "left": 163}, "words": "3.给小鼠和大鼠人用剂量的50倍本品进行生育实验表明未对生育能力"}], "language": 3}